NEW DELHI(NewsTimePro): Drug company Zids Cadilla has asked the Drug Controller General of India (DCGI) for permission to use the hepatitis drug pagedylated interferon olfa-2B in coronavirus infections. According to Zids Cadilla on Monday, the third phase of the pegylated interferon olfa-2 trial has been encouraging in the treatment of covid-infected people. According to the company, the company claims that the coronavirus is recovering quickly after its use in the coronavirus. The company, on the other hand, also claims that there is no side effect on the patient’s body after taking the medication. It is expected that the company will be allowed to use it in India after the company’s claim.
Related Posts
ପରୀକ୍ଷା ହଲ ବାହାରେ ବଡ଼ ଦୁନିଆ ଅଛି: ପ୍ରଧାନମନ୍ତ୍ରୀ ନରେନ୍ଦ୍ର ମୋଦି
- NTP Bureau Report
- 29/01/2019
- 0
ନୂଆଦିଲ୍ଲୀ: ଛାତ୍ରଛାତ୍ରୀମାନଙ୍କ ଆଗାମୀ ପରୀକ୍ଷା ପୂର୍ବରୁ ଆଜି ପ୍ରଧାନମନ୍ତ୍ରୀ ନରେନ୍ଦ୍ର ମୋଦି ଛାତ୍ରଛାତ୍ରୀ, ଶିକ୍ଷକଶିକ୍ଷୟିତ୍ରୀ ଓ ଅଭିଭାବକମାନଙ୍କ ସହିତ ଆଲୋଚନା କରିଛନ୍ତି। ଦିଲ୍ଲୀର ତାଲକଟୋରା ଷ୍ଟାଡ଼ିୟମଠାରେ ୨ହଜାରୁ ଉର୍ଧ୍ୱ ଛାତ୍ରଛାତ୍ରୀ, ଶିକ୍ଷକ ଓ ଅଭିଭାବକମାନଙ୍କ […]
A young man has been arrested for sexually abusing a seven-year-old girl in a school toilet
- NTP Bureau Report
- 14/06/2021
- 0
Nagpur: (NewsTimePro):A seven-year-old girl has been arrested on charges of molesting a schoolgirl in a school in Nagpur district of Maharashtra. That’s what the police […]
Oil Minister 4 Days Visit To Russia & Japan
- NTP Bureau Report
- 22/10/2019
- 0
NewDelhi(News Time Pro): Union Minister for Oil and Gas Dharmendra Pradhan four-day visit to Japan and Russiafrom October 22 to 26. A statement by the […]